cDCs1 exert the most potent anti-tumor functions resulting from the ability to release IL-12 and orchestrate anti-tumor CD8+ T cell effectors functions, through cross-presentation and induction of anti-tumor CD4+ Th1 type cells [121]. The gene discussed is CD8A; the disease is neoplasm.